MedTrace Logo

Intensive Statin Therapy Effect on Post-Operative Atrial Fibrillation (POAF)

NCT02029534 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-06-16

No results posted yet for this study

Summary

This study will compare the effects of 20 mg of atorvastatin to 80 mg of atorvastatin for the prevention of atrial fibrillation after cardiothoracic surgery. The study hypothesis is that 80 mg of atorvastatin will be more effective at preventing atrial fibrillation compared to 20 mg.

Conditions

  • Cardiothoracic Surgery
  • Post-operative Atrial Fibrillation

Interventions

DRUG

Atorvastatin 20 mg

DRUG

Atorvastatin 80 mg

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Aiman Smer, MBBCh · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029534 on ClinicalTrials.gov